CHIEF FINANCIAL OFFICER
Fri, May 23, 2025
May 23
exercised or converted securities in ACLX
22,429 shares @ $0.00
Decreased holdings by -100.00%
Net across this filing: +56.50% (+10,194 shares)
Option Exercise
Sale tied to a same-time option exercise
ACLXArcellx, Inc.
Health CareBiotechnology